Minerva Neurosciences, Inc. Research and Development Expense
Minerva Neurosciences, Inc. (NERV) reported Research and Development Expense of $7.19 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-07
- Minerva Neurosciences, Inc. research and development expense for the quarter ending 2026-06-30 was $7.19M, a 453.70% increase year-over-year.
- Minerva Neurosciences, Inc. research and development expense for the quarter ending 2026-03-31 was $5.25M, a 285.70% increase year-over-year.
- Minerva Neurosciences, Inc. research and development expense for the quarter ending 2025-12-31 was $2.17M, a 9.62% increase year-over-year.
- Minerva Neurosciences, Inc. research and development expense for the quarter ending 2025-09-30 was $925.38K, a 50.98% decline year-over-year.
- Minerva Neurosciences, Inc. research and development expense for fiscal 2025 was $5.76M, a 51.60% decline from fiscal 2024.
- Minerva Neurosciences, Inc. research and development expense for fiscal 2024 was $11.90M, a 6.35% decline from fiscal 2023.
- Minerva Neurosciences, Inc. research and development expense for fiscal 2023 was $12.71M, a 13.27% decline from fiscal 2022.
- Minerva Neurosciences, Inc. research and development expense for fiscal 2022 was $14.65M, a 54.28% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.19M 10-Q · filed 2026-08-07 | $12.44M 10-Q · filed 2026-08-07 | $14.62M derived: sum of 3 quarters · filed 2026-08-07 | $15.54M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $5.25M 10-Q · filed 2026-05-05 | $7.43M derived: sum of 2 quarters · filed 2026-05-05 | $8.35M derived: sum of 3 quarters · filed 2026-05-05 | $9.65M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $3.10M derived: sum of 2 quarters · filed 2026-03-11 | $4.40M derived: sum of 3 quarters · filed 2026-08-07 | $5.76M 10-K · filed 2026-03-11 |
| 2025-09-30 | $925.38K 10-Q · filed 2025-11-05 | $2.22M derived: sum of 2 quarters · filed 2026-08-07 | $3.59M 10-Q · filed 2025-11-05 | $5.57M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $1.30M 10-Q · filed 2026-08-07 | $2.66M 10-Q · filed 2026-08-07 | $4.64M derived: sum of 3 quarters · filed 2026-08-07 | $6.53M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $1.36M 10-Q · filed 2026-05-05 | $3.35M derived: sum of 2 quarters · filed 2026-05-05 | $5.23M derived: sum of 3 quarters · filed 2026-05-05 | $9.09M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $3.87M derived: sum of 2 quarters · filed 2026-03-11 | $7.73M derived: sum of 3 quarters · filed 2026-03-11 | $11.90M 10-K · filed 2026-03-11 |
| 2024-09-30 | $1.89M 10-Q · filed 2025-11-05 | $5.75M derived: sum of 2 quarters · filed 2025-11-05 | $9.92M 10-Q · filed 2025-11-05 | $14.64M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $3.86M 10-Q · filed 2025-08-14 | $8.03M 10-Q · filed 2025-08-14 | $12.75M derived: sum of 3 quarters · filed 2025-08-14 | $16.19M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $4.17M 10-Q · filed 2025-05-13 | $8.89M derived: sum of 2 quarters · filed 2025-05-13 | $12.33M derived: sum of 3 quarters · filed 2025-05-13 | $14.22M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $4.72M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $8.16M derived: sum of 2 quarters · filed 2025-02-25 | $10.05M derived: sum of 3 quarters · filed 2025-02-25 | $12.71M 10-K · filed 2025-02-25 |
| 2023-09-30 | $3.44M 10-Q · filed 2024-11-05 | $5.33M derived: sum of 2 quarters · filed 2024-11-05 | $7.98M 10-Q · filed 2024-11-05 | $11.17M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $1.89M 10-Q · filed 2024-08-06 | $4.54M 10-Q · filed 2024-08-06 | $7.73M derived: sum of 3 quarters · filed 2024-08-06 | $10.10M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $2.65M 10-Q · filed 2024-05-01 | $5.84M derived: sum of 2 quarters · filed 2024-05-01 | $8.21M derived: sum of 3 quarters · filed 2024-05-01 | $12.34M derived: sum of 4 quarters · filed 2024-05-01 |
| 2022-12-31 | $3.19M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $5.56M derived: sum of 2 quarters · filed 2024-02-22 | $9.69M derived: sum of 3 quarters · filed 2024-02-22 | $14.65M 10-K · filed 2024-02-22 |
| 2022-09-30 | $2.37M 10-Q · filed 2023-11-07 | $6.50M derived: sum of 2 quarters · filed 2023-11-07 | $11.46M 10-Q · filed 2023-11-07 | $30.21M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $4.13M 10-Q · filed 2023-08-01 | $9.09M 10-Q · filed 2023-08-01 | $27.84M derived: sum of 3 quarters · filed 2023-08-01 | $32.35M derived: sum of 4 quarters · filed 2023-08-01 |
| 2022-03-31 | $4.96M 10-Q · filed 2023-05-15 | $23.71M derived: sum of 2 quarters · filed 2023-05-15 | $28.22M derived: sum of 3 quarters · filed 2023-05-15 | $33.74M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $18.75M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $23.26M derived: sum of 2 quarters · filed 2023-03-08 | $28.78M derived: sum of 3 quarters · filed 2023-03-08 | $32.04M 10-K · filed 2023-03-08 |
| 2021-09-30 | $4.51M 10-Q · filed 2022-11-09 | $10.03M derived: sum of 2 quarters · filed 2022-11-09 | $13.29M 10-Q · filed 2022-11-09 | $16.84M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $5.52M 10-Q · filed 2022-08-09 | $8.78M 10-Q · filed 2022-08-09 | $12.33M derived: sum of 3 quarters · filed 2022-08-09 | $16.97M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $3.26M 10-Q · filed 2022-05-04 | $6.81M derived: sum of 2 quarters · filed 2022-05-04 | $11.45M derived: sum of 3 quarters · filed 2022-05-04 | $17.22M derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | $3.55M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $8.19M derived: sum of 2 quarters · filed 2022-03-01 | $13.96M derived: sum of 3 quarters · filed 2022-03-01 | $22.04M 10-K · filed 2022-03-01 |
| 2020-09-30 | $4.64M 10-Q · filed 2021-11-08 | $10.41M derived: sum of 2 quarters · filed 2021-11-08 | $18.49M 10-Q · filed 2021-11-08 | $47.01M derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | $5.77M 10-Q · filed 2021-08-02 | $13.85M 10-Q · filed 2021-08-02 | $42.37M derived: sum of 3 quarters · filed 2021-08-02 | $52.05M derived: sum of 4 quarters · filed 2021-08-02 |
| 2020-03-31 | $8.08M 10-Q · filed 2021-05-12 | $36.61M derived: sum of 2 quarters · filed 2021-05-12 | $46.28M derived: sum of 3 quarters · filed 2021-05-12 | $54.60M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $28.52M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $38.20M derived: sum of 2 quarters · filed 2021-03-08 | $46.52M derived: sum of 3 quarters · filed 2021-03-08 | $58.12M 10-K · filed 2021-03-08 |
| 2019-09-30 | $9.67M 10-Q · filed 2020-11-02 | $17.99M derived: sum of 2 quarters · filed 2020-11-02 | $29.60M 10-Q · filed 2020-11-02 | $38.61M derived: sum of 4 quarters · filed 2020-11-02 |
| 2019-06-30 | $8.32M 10-Q · filed 2020-08-03 | $19.93M 10-Q · filed 2020-08-03 | $28.93M derived: sum of 3 quarters · filed 2020-08-03 | $37.30M derived: sum of 4 quarters · filed 2020-08-03 |
| 2019-03-31 | $11.61M 10-Q · filed 2020-05-04 | $20.61M derived: sum of 2 quarters · filed 2020-05-04 | $28.98M derived: sum of 3 quarters · filed 2020-05-04 | $38.05M derived: sum of 4 quarters · filed 2020-05-04 |
| 2018-12-31 | $9.01M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $17.38M derived: sum of 2 quarters · filed 2020-03-09 | $26.44M derived: sum of 3 quarters · filed 2020-03-09 | $34.89M 10-K · filed 2020-03-09 |
| 2018-09-30 | $8.37M 10-Q · filed 2019-11-04 | $17.43M derived: sum of 2 quarters · filed 2019-11-04 | $25.88M 10-Q · filed 2019-11-04 | $32.42M derived: sum of 4 quarters · filed 2019-11-04 |
| 2018-06-30 | $9.06M 10-Q · filed 2019-08-05 | $17.51M 10-Q · filed 2019-08-05 | $24.05M derived: sum of 3 quarters · filed 2019-08-05 | $33.01M derived: sum of 4 quarters · filed 2019-08-05 |
| 2018-03-31 | $8.45M 10-Q · filed 2019-05-06 | $14.99M derived: sum of 2 quarters · filed 2019-05-06 | $23.95M derived: sum of 3 quarters · filed 2019-05-06 | $31.09M derived: sum of 4 quarters · filed 2019-05-06 |
| 2017-12-31 | $6.54M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $15.50M derived: sum of 2 quarters · filed 2019-03-12 | $22.64M derived: sum of 3 quarters · filed 2019-03-12 | $30.26M 10-K · filed 2019-03-12 |
| 2017-09-30 | $8.96M 10-Q · filed 2018-11-05 | $16.10M derived: sum of 2 quarters · filed 2018-11-05 | $23.71M 10-Q · filed 2018-11-05 | $30.21M derived: sum of 4 quarters · filed 2018-11-05 |
| 2017-06-30 | $7.14M 10-Q · filed 2018-08-02 | $14.76M 10-Q · filed 2018-08-02 | $21.26M derived: sum of 3 quarters · filed 2018-08-02 | $27.11M derived: sum of 4 quarters · filed 2018-08-02 |
| 2017-03-31 | $7.61M 10-Q · filed 2018-05-03 | $14.11M derived: sum of 2 quarters · filed 2018-05-03 | $19.97M derived: sum of 3 quarters · filed 2018-05-03 | $22.68M derived: sum of 4 quarters · filed 2018-05-03 |
| 2016-12-31 | $6.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $12.35M derived: sum of 2 quarters · filed 2018-03-12 | $15.07M derived: sum of 3 quarters · filed 2018-03-12 | $20.44M 10-K · filed 2018-03-12 |
| 2016-09-30 | $5.85M 10-Q · filed 2017-11-06 | $8.57M derived: sum of 2 quarters · filed 2017-11-06 | $13.94M 10-Q · filed 2017-11-06 | $20.20M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | $2.71M 10-Q · filed 2017-08-03 | $8.09M 10-Q · filed 2017-08-03 | $14.35M derived: sum of 3 quarters · filed 2018-03-12 | $18.18M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | $5.37M 10-Q · filed 2017-05-04 | $11.63M derived: sum of 2 quarters · filed 2018-03-12 | $15.46M derived: sum of 3 quarters · filed 2018-03-12 | $19.95M derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | $6.26M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $10.09M derived: sum of 2 quarters · filed 2018-03-12 | $14.57M derived: sum of 3 quarters · filed 2018-03-12 | $18.53M 10-K · filed 2018-03-12 |
| 2015-09-30 | $3.83M 10-Q · filed 2016-11-03 | $8.31M derived: sum of 2 quarters · filed 2016-11-03 | $12.27M 10-Q · filed 2016-11-03 | $15.24M derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-06-30 | $4.48M 10-Q · filed 2016-08-04 | $8.45M 10-Q · filed 2016-08-04 | $11.41M derived: sum of 3 quarters · filed 2017-03-13 | $36.15M derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-03-31 | $3.96M 10-Q · filed 2016-05-03 | $6.93M derived: sum of 2 quarters · filed 2017-03-13 | $31.67M derived: sum of 3 quarters · filed 2017-03-13 | $46.22M derived: sum of 4 quarters · filed 2017-03-13 |
| 2014-12-31 | $2.97M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $27.71M derived: sum of 2 quarters · filed 2017-03-13 | $42.26M derived: sum of 3 quarters · filed 2017-03-13 | $42.91M 10-K · filed 2017-03-13 |
| 2014-09-30 | $24.74M 10-Q · filed 2015-11-05 | $39.29M derived: sum of 2 quarters · filed 2015-11-05 | $39.94M 10-Q · filed 2015-11-05 | $40.04M derived: sum of 4 quarters · filed 2015-11-05 |
| 2014-06-30 | $14.55M 10-Q · filed 2015-08-05 | $15.14M 10-Q · filed 2015-08-05 | $15.30M derived: sum of 3 quarters · filed 2015-08-05 | $15.50M derived: sum of 4 quarters · filed 2015-08-05 |
| 2014-03-31 | $585.94K 10-Q · filed 2015-05-07 | $749.98K derived: sum of 2 quarters · filed 2015-05-07 | $940.64K derived: sum of 3 quarters · filed 2015-05-07 | $1.19M derived: sum of 4 quarters · filed 2015-05-07 |
| 2013-12-31 | $164.04K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $354.71K derived: sum of 2 quarters · filed 2015-03-26 | $604.55K derived: sum of 3 quarters · filed 2015-03-26 | $708.49K 10-K · filed 2015-03-26 |
| 2013-09-30 | $190.66K 10-Q · filed 2014-11-06 | $440.51K derived: sum of 2 quarters · filed 2014-11-06 | $544.45K 10-Q · filed 2014-11-06 | |
| 2013-06-30 | $249.84K 10-Q · filed 2014-08-07 | $353.78K 10-Q · filed 2014-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |